Selective resection of colorectal liver metastases

European Journal of Surgical Oncology

Volumn 33, Issue 2, 2007, Pages 174-182

  Tamandl, D ^a   Gruenberger, B ^a   Herberger, B ^a   Schoppmann, S ^a   Bodingbauer, M ^a   Schindl, M ^a   Puhalla, H ^a   Fleischmann, E ^a   Schima, W ^a   Jakesz, R ^a   Laengle, F ^a   Gruenberger, T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Colorectal cancer liver metastases; Liver resection; Morbidity and mortality; Neoadjuvant chemotherapy; Perioperative care

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CEFUROXIME; FENTANYL; FLUOROURACIL; IRINOTECAN; METRONIDAZOLE; MITOMYCIN C; OXALIPLATIN; PROPOFOL; ROCURONIUM; SEVOFLURANE; TUMOR MARKER;

ABDOMINAL ABSCESS; ADJUVANT CHEMOTHERAPY; ARTICLE; ASCITES; BILE LEAKAGE; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESPONSE; GENDER; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; LIVER METASTASIS; LIVER SURGERY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MORBIDITY; MULTIVARIATE ANALYSIS; OPERATION DURATION; PERIOPERATIVE PERIOD; PLEURA EFFUSION; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; REOPERATION; SAFETY; SURGICAL MORTALITY; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AUSTRIA; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33847400166     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.09.008     Document Type: Article

References (33)

1. Fong Y., Fortner J., Sun R.L., Brennan M.F., and Blumgart L.H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230 (1999) 309-318 discussion 318-21
2. Nordlinger B., Guiguet M., Vaillant J.C., et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77 (1996) 1254-1262
3. Scheele J., Altendorf-Hofmann A., Grube T., et al. Resection of colorectal liver metastases. What prognostic factors determine patient selection?. Chirurg 72 (2001) 547-560
4. Abdalla E.K., Vauthey J.N., Ellis L.M., et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239 (2004) 818-825 discussion 825-7
5. Leonard G.D., Brenner B., and Kemeny N.E. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 23 (2005) 2038-2048
6. Kato T., Yasui K., Hirai T., et al. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 Suppl. 10 (2003) S22-S31
7. Khatri V.P., Petrelli N.J., and Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?. J Clin Oncol 23 (2005) 8490-8499
8. Adam R., Pascal G., Castaing D., et al. Tumour progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?. Ann Surg 240 (2004) 1052-1061 discussion 1061-4
9. Allen P.J., Kemeny N., Jarnagin W., et al. Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases. J Gastrointest Surg 7 (2003) 109-115 discussion 116-7
10. Vauthey J.N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
11. Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
12. Nagano Y., Nojiri K., Matsuo K., et al. The impact of advanced age on hepatic resection of colorectal liver metastases. J Am Coll Surg 201 (2005) 511-516
13. Figueras J., Valls C., Rafecas A., et al. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 88 (2001) 980-985
14. Choti M.A., Sitzmann J.V., Tiburi M.F., et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235 (2002) 759-766
15. Laurent C., Sa Cunha A., Couderc P., Rullier E., and Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90 (2003) 1131-1136
16. Morise Z., Sugioka A., Fujita J., et al. Does repeated surgery improve the prognosis of colorectal liver metastases?. J Gastrointest Surg 10 (2006) 6-11
17. Strasberg S.M. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 12 (2005) 351-355
18. Zacharias T., Jaeck D., Oussoultzoglou E., Bachellier P., and Weber J.C. First and repeat resection of colorectal liver metastases in elderly patients. Ann Surg 240 (2004) 858-865
19. Minagawa M., Makuuchi M., Torzilli G., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231 (2000) 487-499
20. Davila J.A., Rabeneck L., Berger D.H., and El-Serag H.B. Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci 50 (2005) 1722-1728
21. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240 (2004) 644-657 discussion 657-8
22. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 (2002) 397-406 discussion 406-7
23. Gruenberger T., Schuell B., Puhalla H., et al. Changes in liver surgery for colorectal cancer liver metastases under neoadjuvant treatment strategies. Eur Surg 36 (2005) 317-321
24. Gruenberger T., Gruenberger B., Becherer A., Kettenbach J., Diekmann K., and Schima W. Interdisciplinary management of colorectal cancer liver metastases. Eur Surg 38 (2006) 107-111
25. Taylor M., Forster J., Langer B., et al. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 173 (1997) 467-471
26. Gayowski T.J., Iwatsuki S., Madariaga J.R., et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116 (1994) 703-710 discussion 710-1
27. Kokudo N., Tada K., Seki M., et al. Anatomical major resection versus non-anatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181 (2001) 153-159
28. Yamamoto J., Kosuge T., Shimada K., et al. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 178 (1999) 275-281
29. Ambiru S., Miyazaki M., Isono T., et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 42 (1999) 632-639
30. Ueno H., Mochizuki H., Hashiguchi Y., et al. Predictors of extrahepatic recurrence after resection of colorectal liver metastases. Br J Surg 91 (2004) 327-333
31. Jatzko G.R., Lisborg P.H., Stettner H.M., and Klimpfinger M.H. Hepatic resection for metastases from colorectal carcinoma - a survival analysis. Eur J Cancer 31A (1995) 41-46
32. Gruenberger T, Schuell B, Kornek G, Scheithauer W. Elderly patients do benefit from oxaliplatin based neoadjuvant chemotherapy in resectable colorectal cancer liver metastases. In: Journal of Clinical Oncology 2005 ASCO annual meeting proceedings. 23, 3601 [Supplement].
33. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 12 (2005) 900-909